Credit: Glaukos. Epioxa does not require the removal of the corneal epithelium, a step usually required by traditional corneal cross-linking procedures, thereby minimizing pain and recovery time.

Please provide your email address to receive an email when new articles are posted on . FRANKFURT, Germany — In this Healio Video Perspective from the ESCRS winter meeting, Farhad Hafezi, MD, PhD, ...

Please provide your email address to receive an email when new articles are posted on . In our OD-MD practice, cross-linking is performed in-house, and the optometrists do the bulk of the work in ...

Epioxa Provides the Ophthalmic Community and Patients with the First and Only FDA-Approved, Incision-Free, Topical Drug Therapy for Keratoconus Epioxa Represents a Novel, Groundbreaking Therapy for ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma, corneal ...